Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

22

Revenue 2017

Januvia

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Januvia was produced by Merck & Co..

Reference price bill tabled in US House and Senate

Reference price bill tabled in US House and Senate

savings for several other drugs including Pfizer’s hormone replacement therapy Premarin (conjugated oestrogens),   Merck &Co’s Januvia (sitagliptin) for diabetes, and Astellas/Pfizer’s prostate cancer therapy Xtandi (enzalutamide).

Daily Brief: Charity criticises NHSE and Vertex over Orkambi access, Sema scores again, NodThera launched

Daily Brief: Charity criticises NHSE and Vertex over Orkambi access, Sema scores again, NodThera launched This follows data released ahead of the congress which showed the as-yet-unapproved oral semaglutide outperformed market leading oral treatment, Merck &Co’s Januvia, as well as Novo's own

Novo’s diabetes pill defeats Merck’s Januvia in trial

Novo’s diabetes pill defeats Merck’s Januvia in trial Comparing oral semaglutide to Merck &Co’s DPP-4 inhibitor Januvia (sitagliptin), PIONEER 7 investigated the efficacy and safety of the GLP-1 inhibitor in people with type 2 diabetes.

FDA’s year-end approvals take annual tally to 46

FDA’s year-end approvals take annual tally to 46 Merck and Pfizer are hoping that Steglujan will benefit from piggy-backing on Merck’s Januvia - the top-selling DPP-4 inhibitor - backed by some strong clinical data for the combination

Merck pulls Keytruda filing in Europe, despite US approval

Merck pulls Keytruda filing in Europe, despite US approval portfolio after its Januvia/Janumet diabetes franchise.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics